Imiquimod 5% cream: A treatment option for keratoacanthoma? [2]

European Journal of Dermatology

Volumn 13, Issue 4, 2003, Pages 415-

  Prinz, Jörg Christoph ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

CONSERVATIVE TREATMENT; CREAM; DRUG EFFICACY; DRUG INDICATION; HUMAN; KERATOACANTHOMA; LETTER;

EID: 0042160130     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Peris K, Micantonio T, Fargnoli MC. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream. Eur J Dermatol 2003; 13: 413-4
2. Dendorfer M, Oppel T, Wollenberg A Prinz JC. Topical treatment with imiquimod may induce regression of facial keratooconthoma. Eur J Dermatol 2003; 13: 80-2.
3. Lucente FE. Giant keratoacanthomo of the nose. Otolaryngol Head Neck Surg 1985; 93: 112-6.
4. de Visscher JG, van der Wal JE, Starink TM, Tiwari RM, and van der Waal I. Giant keratoacanthoma of the lower lip: Report of a case of spontaneous regression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81: 193-6.
5. Saito M, Sasaki Y, Yamazaki N, Shimizu H. Self-involution of giant keratoacanthoma on the tip of the nose. Plast Reconstr Surg 2003; 111: 1561-2.
6. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-2.